Profile Image

Staff Profile

Edit

Career Summary

Biography

Nicole Verrills is an early career investigator who already has numerous research achievements. Her PhD was awarded from Macquarie University in 2005, for which she received a Vice-Chancellors Commendation for Excellence in Research. Her research interests centre on understanding the molecular changes involved in cancer progression and chemotherapy resistance. By using powerful proteomics techniques, including being one of the first in Australia to use difference in-gel electrophoresis (DIGE) technology, she has discovered novel protein alterations that confer chemotherapy resistance in childhood leukaemia. These proteins are now targets for ongoing investigations to develop improved therapies for relapsed leukaemia patients (Aus Patent PCT/AU2004/000331; US Patent 10/549831 - Determining Drug Resistance). This research is internationally competitive and recognised through continued publications, presentations at international and national meetings, and international and national awards. These include the 2004 Biochemical Journal Young Investigator Award, presented to the best young researcher at the 12th International Conference on Second Messengers and Phosphoproteins, Montreal, Canada; the Merck Sharp Dohm Best of the Best Award and the Cure Cancer Australia Foundation Award, both presented at the 2004 Australian Health and Medical Research (ASMR) Congress. In 2003 Dr Verrills was awarded the University of Sydney Medal for Excellence in Medical Research, presented to the best young researcher at the ASMR NSW Conference, and was a finalist in the Cure Cancer Australia Foundations Young Researcher of the Year Award. Her research publications appear in journals of high impact and are already well cited (over 230 to date). The importance of her work has been featured in opinion articles in the Journal of the National Cancer Institute (Fojo, T (2006) JNCI 98: 1363) and Chemistry and Biology (Ojima and Ferlini (2003) Chem Biol 10: 583).

In 2006 Dr Verrills received a highly competitive and prestigious NHMRC Peter Doherty (Biomedical) Postdoctoral Fellowship. Through this fellowship she also received a scholarship to the Australian Academy of Science Science at the Shine Dome meeting. In 2006 she became the inaugural recipient of the Hunter Medical Research Institute (HMRI) Competitive Research Fund for Early Career Researchers in Cancer, and she has recently received grant funding from the Cure Cancer Australia Foundation. Her expertise in the field of proteomics and cancer biology results in invitations to peer review manuscripts for a variety of journals and grant applications, and invitations to present seminars. She has a strong determination to translate her research findings into improved clinical outcome for cancer patients, and has experience in patenting research discoveries.

Dr Verrills is currently supervising an Honours and three PhD students. She has a strong commitment to the advancement and promotion of medical research in our society. Dr Verrills was on the organising committee for the HMRI Conference on Translational Cancer Research, Newcastle, 2006, and again for the upcoming 2008 HMRI Cancer Conference. She also convenes local HMRI Cancer Seminars and sits on the HMRI Cancer Research Group Steering committee. As part of her community involvement she has disseminated her research through the print, radio, and television media, and has presented her research to the local community as a guest speaker at Rotary Clubs, the Hunter Seniors Association, and HMRI charity events.

Dr Nicole Verrills has established a number of productive collaborations with researchers both nationally and abroad. During her time at the Childrens Cancer Institute Australia (CCIA), Dr Verrills established collaborative projects with research groups outside her own, including Prof Michelle Haber of the Experimental Therapeutics Program, and Prof Murray Norris of the Molecular Diagnostics Program [NV7,10], Dr Richard Lock of the Leukaemia Biology Program [NV4], and Prof Glen Marshall of the Molecular Carcinogenesis Program [NV3]. She also established collaborations with Prof Peter Gunning from the Oncology Research Unit, The Childrens Hospital at Westmead [NV3,6], and international researchers Prof Brigit Hill from Pierre Fabre Research Institute, France [NV13] and Martin Larsen from the Department of Biochemistry and Molecular Biology, University of Southern Denmark [NV3], Dr Larsen is an international leader in phospho-proteomics, and Dr Verrills continues to collaborate with him at Newcastle University. During this time, Dr Verrills was also pivotal in establishing an ongoing collaboration between CCIA and APAF [NV8-10].

Since coming to Newcastle University, Dr Verrills has continued to establish research collaborations. Dr Verrills has established her own research program, Cancer Biology, which collaborates extensively with A/Prof Alistair Sim (Phosphatase Signalling) [NV1] and Prof Leonie Ashman (Oncology Research) at Newcastle University and the Hunter Medical Research Institute (HMRI). She has been pivotal in establishing a proteomics research project as part of the Asthma and Airways CRC, together with A/Prof Ailstair Sim at Newcastle University and Prof Peter Gibson at the John Hunter Hospital. She has also instigated collaborations with international leaders in cancer research, such as A/Prof Danilo Perrotti from the Ohio State University, USA, with whom a co-authored paper on PP2A activating drugs in chronic myeloid leukaemia is currently under review, Dr William Hahn from the Dana-Faber Cancer Institute and Harvard Medical School, USA, and a leader in phosphatase research A/Prof Stefan Strack from the University of Iowa, USA.

Qualifications

  • Bachelor of Science (Honours), Macquarie University, 12/05/1999

Research

Research keywords

  • Breast Cancer
  • Cancer
  • Chemotherapy resistance
  • Leukaemia
  • Protein phosphatase 2A
  • Proteomics
  • Signal transduction

Research expertise

Dr Verrills research interests centre on understanding the molecular changes involved in cancer progression and chemotherapy resistance. By using powerful proteomics techniques, including being one of the first in Australia to use difference in-gel electrophoresis (DIGE) technology, she has discovered novel protein alterations that confer chemotherapy resistance in childhood leukaemia. These proteins are now targets for ongoing investigations to develop improved therapies for relapsed leukaemia patients. Dr Verrills is currently investigating the role of the signaling protein, protein phosphatase 2A, in cancer. Using shRNA and overexpression transfection of normal and cancer cell lines, coupled with molecular and biochemical analyses such as PCR, immunoblotting, immunoprecipitation, immunofluorescence, 2D-DIGE and mass spectrometry, she is determining the role of mutant PP2A and specific PP2A subunits in the development of leukaemia and breast cancer.

Fields of Research

CodeDescriptionPercentage
060100Biochemistry And Cell Biology75
111500Pharmacology And Pharmaceutical Sciences15
111200Oncology And Carcinogenesis10

Memberships

Body relevant to professional practice.

  • Member - American Association of Cancer Research
  • Member - Australian Society for Medical Research

Committee/Associations (relevant to research).

  • Committee member - HMRI Cancer Research Group Steering Committee
  • Organising committee member - HMRI Conference on Translational Cancer Research

Appointments

Peter Doherty Biomedical Fellow
National Health & Medical Research Council (Australia)
01/01/2006 - 01/07/2010

Awards

Honours.

1998Bill Cantwell prize for Excellence in Biology
Macquarie University (Australia)
This award is given to exceptional students who top the honours year.

Other

2003Australian Postgraduate Award 2001-2003
Macquarie University (Australia)

PhD Scholarship

2003Australian Proteome Analysis Facility Scholarship 2001-2003
Australian Proteome Analysis Facility (Australia)
This award gave a top-up to the APA for my PhD candidature.

Recognition.

20052005 - Doctor of Philosophy, Vice Chancellor Commendation.
Macquarie University (Australia)
My PhD thesis was passed without need for corrections and I received a letter of commendation from the Vice Chancellor for excellence in research.
20032003 - Cure Cancer Australia Foundations Young Researcher of the Year Award Finalist.
Cure Cancer Australia Foundation (Australia)
Cure Cancer Australia Foundation is a major supporter of cancer research, raising funds to provide competitive research funding schemes and research awards. The Young Researcher Awards are a major event within the Australian medical and scientific communities as the process draws the very best young cancer researchers from right around Australia.

Research Award.

20042004 - Cure Cancer Australia Foundation Award
Cure Cancer Australia Foundation (Australia)
This prize was awarded for the best postdoctoral or student presentation in cancer research at the National Scientific Meeting of the Australian Society for Medical Research.
20042004 - Merck Sharp Dohm Best of the Best Award Australian Health and Medical Research Congress
Australian Society of Medical Research (Australia)
This is a highly competitive and prestigious research award. There were 28 societies represented at this meeting and each society put forward their best candidate, drawn from postdoctoral scientists and students. I shared the overall top prize with one other candidate.
2004Biochemical Journal Young Investigator Award - 12th International Conference on Second Messengers an
The Biochemical Journal (Canada)
The Biochemical Journal is Europes leading scientific journal in the field and gives the award to the most deserving young scientist based upon presentation of their work to a judging panel of international experts. This award is highly competitive and prestigious, with 157 international postdoctoral and student candidates in 2004.
20032003 - University of Sydney Medal for Excellence in Medical Research
Australian Society of Medical Research (Australia)
This prestigious award was presented for the best postdoctoral or student research presentation at the NSW state branch ASMR meeting.

Invitations

Amersham Biosciences Technical Seminar Series. Brisbane; Adelaide; Melbourne; Sydney.
GE Biosciences, Australia (Conference Presentation - non published.)
2003
Protemics for cancer research
Oncology Research Unit, Childrens Hospital, Westmead., Australia (Invitation to give research seminar)
2003
Proteome analyses reveals novel mechanisms of resistance to anticancer agents.
Oncology Research Unit, Childrens Hospital, Westmead., Australia (Invitation to give research seminar)
2003
New technologies meets functional proteomics.
ComBio 2002, Australia (Invited conference presentation)
2002

Administrative

Administrative expertise

Dr Verrills undetakes many administrative tasks, including managing the budgets for her grants. Some duties include obtaining product quotes, ordering, safety and ethics applications, co-ordinating multi investigator grant applications, and organising research seminar series and workshops.

Teaching

Teaching keywords

  • Cancer
  • Drug resistance
  • Proteomics

Teaching expertise

Dr Verrills is a strong supporter of fostering research students. She has supervised two Honours student (both received 1st Class), and is currently supervising one Honours and three PhD students. Dr Verrills is a fulltime research academic, however she does guest lecture for 2nd and 3rd year BBiomed Sci courses in Proteomics, Bioinformatics, Cancer, and Drug Resistance.

Edit

Publications

No publications.

Edit

Grants and Funding

Summary

Number of grants46
Total funding$7,592,562

For project grants received where the lead institution is other than the University of Newcastle, details are shown in italics.

- Indicates that the researcher may be seeking students for this project.

Click on a grant title below to expand the full details for that specific grant.

2013 (3 grants)

Targeting PP2A to improve the therapeutic efficacy of mutant BRAF inhibitors in melanoma$359,250
Funding Body: Cancer Council NSW

Project Team
Professor Xu Dong Zhang, Doctor Nikki Verrills, Doctor Chen Chen Jiang
SchemeRole
Research GrantInvestigator
Total AmountFunding StartFunding Finish
$359,25020132015
GNo:G1200388

Ultra-Low Temperature Cryogenic Freezer$24,596
Funding Body: NHMRC (National Health & Medical Research Council)

Proteomics of Cancer$6,000
Funding Body: Hunter Medical Research Institute

Project Team
Doctor Matt Dun, Doctor Nikki Verrills, Dr Anoop Enjeti
SchemeRole
Project GrantInvestigator
Total AmountFunding StartFunding Finish
$6,00020132013
GNo:G1300054

2012 (8 grants)

The Hunter Cancer Biobank (HCB): Maximising community value through validation, annotation and distribution throughout NSW$292,300
Funding Body: Cancer Institute NSW

Project Team
Professor John Forbes, Conjoint Professor Stephen Ackland, Professor Rodney Scott, Conjoint Associate Professor Barbara Young, Professor Hubert Hondermarck, Conjoint Professor Leonie Ashman, Professor Xu Dong Zhang, Doctor Kelly Kiejda, Doctor Nikki Verrills, Doctor Jennette Sakoff, Ms Janine Lombard, Doctor Jude Weidenhofer, Doctor Pradeep Tanwar
SchemeRole
Infrastructure GrantsInvestigator
Total AmountFunding StartFunding Finish
$292,30020122014
GNo:G1200798

Activating a tumour suppressor for leukaemia therapy$260,000
Funding Body: Cancer Council NSW

Project Team
Doctor Nikki Verrills, Dr Anthony Don, Dr Anoop Enjeti, Associate Professor Jonathan Morris
SchemeRole
Research GrantChief Investigator
Total AmountFunding StartFunding Finish
$260,00020122014
GNo:G1100512

Activating a tumour suppressor for leukaemia therapy they receive$100,000
Funding Body: Cure Cancer Australia Foundation

Project Team
Doctor Nikki Verrills, Dr Anthony Don, Dr Anoop Enjeti, Associate Professor Jonathan Morris
SchemeRole
Research GrantChief Investigator
Total AmountFunding StartFunding Finish
$100,00020122012
GNo:G1200007

Microscopic illumination system for advanced fluorescent protein technology$34,000
Funding Body: NHMRC (National Health & Medical Research Council)

Project Team
Doctor Rick Thorne, Professor Xu Dong Zhang, Doctor Murray Cairns, Doctor Nikki Verrills, Doctor Charles De Bock, Doctor Jude Weidenhofer, Doctor Severine Roselli, Doctor Kathryn Skelding, Conjoint Professor Leonie Ashman, Professor Hubert Hondermarck
SchemeRole
Equipment GrantInvestigator
Total AmountFunding StartFunding Finish
$34,00020122012
GNo:G1100983

Activating a tumour suppressor for leukaemia therapy$20,000
Funding Body: University of Newcastle

Project Team
Doctor Nikki Verrills
SchemeRole
Near Miss GrantChief Investigator
Total AmountFunding StartFunding Finish
$20,00020122012
GNo:G1200678

Regulation of the cell cycle by phosphorylation dependent targeting of CaMKII$20,000
Funding Body: University of Newcastle

Project Team
Doctor Nikki Verrills, Doctor Kathryn Skelding, Professor John Rostas, Associate Professor Phillip Dickson, Conjoint Professor Keith Jones
SchemeRole
Near Miss GrantChief Investigator
Total AmountFunding StartFunding Finish
$20,00020122012
GNo:G1200679

Role of CaMKII targeting in neuronal susceptibility to excitotoxic cell death$20,000
Funding Body: University of Newcastle

Project Team
Professor John Rostas, Doctor Neil Spratt, Associate Professor Phillip Dickson, Doctor Nikki Verrills
SchemeRole
Near Miss GrantInvestigator
Total AmountFunding StartFunding Finish
$20,00020122012
GNo:G1200673

FASEB Protein Phosphatases, Snowmass, Colorado USA, 15 - 20 July 2012$1,500
Funding Body: University of Newcastle - Faculty of Health

Project Team
Doctor Nikki Verrills
SchemeRole
Travel GrantChief Investigator
Total AmountFunding StartFunding Finish
$1,50020122013
GNo:G1200803

2011 (7 grants)

Molecular characterisation of TRAIL-regulated signal transduction pathways and their role in the development, persistence, and exacerbation of allergic airways disease$615,048
Funding Body: NHMRC (National Health & Medical Research Council)

Project Team
Professor Joerg Mattes, Doctor Nikki Verrills
SchemeRole
Project GrantInvestigator
Total AmountFunding StartFunding Finish
$615,04820112013
GNo:G1000314

Targeting a tumour suppressor, PP2AS for new Leukaemia therapies$600,000
Funding Body: Cancer Institute NSW

Project Team
Doctor Nikki Verrills
SchemeRole
Early Career FellowshipChief Investigator
Total AmountFunding StartFunding Finish
$600,00020112016
GNo:G1000861

Chemical Biology$444,961
Funding Body: University of Newcastle

Preclinical testing of PP2A activating compounds for the treatment of childhood acute lymphoblastic leukaemia$40,000
Funding Body: Hunter Medical Research Institute

Project Team
Doctor Nikki Verrills, Dr Anthony Don
SchemeRole
Paediatric Oncology Project GrantChief Investigator
Total AmountFunding StartFunding Finish
$40,00020112011
GNo:G1001001

Regulation of Breast Cancer Growth by a Novel Phosphorylation-Dependent Targeting Mechanism$35,000
Funding Body: Hunter Medical Research Institute

Project Team
Doctor Kathryn Skelding, Doctor Nikki Verrills, Professor John Rostas
SchemeRole
Breast Cancer Project GrantInvestigator
Total AmountFunding StartFunding Finish
$35,00020112011
GNo:G1001005

Targeting PP2A as a Novel Therapeutic Strategy for mutant FLT3* Acute Myeloid Leukaemia$25,000
Funding Body: Hunter Medical Research Institute

Project Team
Doctor Nikki Verrills, Doctor Kyu-Tae Kim, Dr Anoop Enjeti
SchemeRole
Project GrantChief Investigator
Total AmountFunding StartFunding Finish
$25,00020112011
GNo:G1000990

IMPLEN NanoPhotometer pearl$10,000
Funding Body: NHMRC (National Health & Medical Research Council)

Project Team
Doctor Murray Cairns, Associate Professor Paul Tooney, Associate Professor Alan Brichta, Professor John Rostas, Emeritus Professor Patricia Michie, Conjoint Professor Keith Jones, Professor Ulli Schall, Associate Professor Phillip Dickson, Doctor Frederick Walker, Doctor Rick Thorne, Doctor Chris Dayas, Doctor Nikki Verrills, Doctor Janet Holt, Doctor Severine Roselli, Doctor Kathryn Skelding, Doctor Jude Weidenhofer, Associate Professor Liz Milward, Doctor Charles De Bock, Doctor Julie Merriman-Jones, Doctor Jing Qin Wu, Doctor Bing Liu, Mr Dan Johnstone, Ms Belinda Goldie, Ms Natalie Beveridge
SchemeRole
Equipment GrantInvestigator
Total AmountFunding StartFunding Finish
$10,00020112011
GNo:G1100030

2010 (4 grants)

An Integrated LC-MS-NMR facility for Applications in Proteomics and Organic Chemistry$500,000
Funding Body: ARC (Australian Research Council)

Project Team
Professor Adam McCluskey, Laureate Professor John Aitken, Professor Paul Dastoor, Professor Phillip Robinson, Professor Eileen McLaughlin, Emeritus Professor Geoffrey Lawrance, Professor Marcel Maeder, Professor Hugh Dunstan, Doctor Shaun Roman, Associate Professor Rob Atkin, Doctor Clovia Holdsworth, Doctor Mark Baker, Doctor Nikki Verrills, Professor Gottfried Otting, Associate Professor Brett Nixon, Doctor Xiaojing Zhou, Ms Megan Chircop, Doctor Warwick Belcher
SchemeRole
Linkage Infrastructure Equipment & Facilities (LIEF)Investigator
Total AmountFunding StartFunding Finish
$500,00020102010
GNo:G0190402

An Integrated LC-MS-NMR facility for Applications in Proteomics and Organic Chemistry$280,000
Funding Body: University of Newcastle

ABI 7500 Real Time PCR System $34,000
Funding Body: NHMRC (National Health & Medical Research Council)

Epigenetic methylation of PP2A subunit promoters in breast cancer$25,000
Funding Body: Hunter Children`s Research Foundation

Project Team
Doctor Nikki Verrills, Doctor Martin Horan
SchemeRole
Research GrantChief Investigator
Total AmountFunding StartFunding Finish
$25,00020102010
GNo:G0900148

2009 (4 grants)

An Advanced Mass Spectrometry Facility for Applications in Proteomics and Organic Chemistry$495,000
Funding Body: ARC (Australian Research Council)

Tetraspanin proteins in prostate cancer progression and prognosis$341,000
Funding Body: Cancer Council NSW

Project Team
Conjoint Professor Leonie Ashman, Doctor Nikki Verrills, Conjoint Professor Jim Denham
SchemeRole
Research GrantInvestigator
Total AmountFunding StartFunding Finish
$341,00020092011
GNo:G0188877

Confocal Laser Scanning Microscopy for Live Cell Imaging$275,000
Funding Body: ARC (Australian Research Council)

An Advanced Mass Spectrometry Facility for Applications in Proteomics and Organic Chemistry$50,000
Funding Body: ARC (Australian Research Council)

2008 (5 grants)

HMRI Cancer Research Program - MRSP Infrastructure$1,031,290
Funding Body: Hunter Medical Research Institute

Project Team
Conjoint Professor Stephen Ackland, Conjoint Professor Leonie Ashman, Professor John Forbes, Conjoint Professor Jim Denham, Conjoint Professor Peter Hersey, Professor Gordon Burns, Professor Adam McCluskey, Doctor Nikki Verrills
SchemeRole
MRSP Infrastructure GrantInvestigator
Total AmountFunding StartFunding Finish
$1,031,29020082009
GNo:G0188622

PP2A: a novel target for leukaemia therapy$300,000
Funding Body: Cancer Council NSW

Project Team
Doctor Nikki Verrills, Conjoint Professor Leonie Ashman, Professor Alistair Sim, Associate Professor Danilo Perrotti, Assoc. Prof Timothy Hughes, Dr David Thomas
SchemeRole
Research GrantChief Investigator
Total AmountFunding StartFunding Finish
$300,00020082010
GNo:G0187694

Functional investigations of novel SET splice isoforms in acute myeloid leukaemia and their potential as a therapeutic target.$270,000
Funding Body: Anthony Rothe Memorial Trust

Project Team
Doctor Nikki Verrills
SchemeRole
Research GrantChief Investigator
Total AmountFunding StartFunding Finish
$270,00020082010
GNo:G0188185

Novel Alternative Splice Isoforms of the SET Oncogene in Acute Myeloid Leukaemia $25,000
Funding Body: Hunter Medical Research Institute

Project Team
Doctor Nikki Verrills
SchemeRole
Project GrantChief Investigator
Total AmountFunding StartFunding Finish
$25,00020082008
GNo:G0188462

PP2A: A new target for asthma therapy$20,000
Funding Body: University of Newcastle

Project Team
Professor Alistair Sim, Doctor Nikki Verrills, Professor John Scott, Conjoint Associate Professor Peter Wark
SchemeRole
Near Miss GrantInvestigator
Total AmountFunding StartFunding Finish
$20,00020082008
GNo:G0188395

2007 (7 grants)

FACSAria - Fluorescence activated cell sorter$300,000
Funding Body: Cancer Institute NSW

Project Team
Doctor Nikki Verrills, Conjoint Professor Leonie Ashman, Laureate Professor John Aitken, Professor Eileen McLaughlin, Professor Alistair Sim, Doctor Rick Thorne, Doctor Jennette Sakoff
SchemeRole
Infrastructure GrantsChief Investigator
Total AmountFunding StartFunding Finish
$300,00020072007
GNo:G0187666

The role of protein phosphatase 2A in breast cancer$75,000
Funding Body: Cure Cancer Australia Foundation

Project Team
Doctor Nikki Verrills
SchemeRole
Research GrantChief Investigator
Total AmountFunding StartFunding Finish
$75,00020072007
GNo:G0186797

HMRI Contribution toward FACSAria - Fluorescence activated cell sorter$52,000
Funding Body: Hunter Medical Research Institute

Project Team
Doctor Nikki Verrills, Conjoint Professor Leonie Ashman, Laureate Professor John Aitken, Professor Eileen McLaughlin, Professor Alistair Sim, Doctor Rick Thorne, Doctor Jennette Sakoff
SchemeRole
Equipment GrantChief Investigator
Total AmountFunding StartFunding Finish
$52,00020072007
GNo:G0188207

Differential regulation of human mast cell degranulation by discrete forms of protein phosphatase 2A$50,000
Funding Body: Asthma Foundation of New South Wales

Project Team
Professor Alistair Sim, Doctor Nikki Verrills, Professor Paul Foster, Conjoint Associate Professor Peter Wark, Conjoint Professor Peter Gibson, Dr Gregory Kranias
SchemeRole
Research GrantInvestigator
Total AmountFunding StartFunding Finish
$50,00020072007
GNo:G0187247

The tumour suppressor gene, PP2A, in breast cancer and its potential as a new target for therapy$29,930
Funding Body: Ramaciotti Foundations

Project Team
Doctor Nikki Verrills
SchemeRole
Research GrantChief Investigator
Total AmountFunding StartFunding Finish
$29,93020072007
GNo:G0188055

Polymerase Chain Reaction (PCR) machine and Spectrophotometer$20,000
Funding Body: NHMRC (National Health & Medical Research Council)

Project Team
Conjoint Professor Leonie Ashman, Professor Alistair Sim, Doctor Nikki Verrills
SchemeRole
Equipment GrantInvestigator
Total AmountFunding StartFunding Finish
$20,00020072007
GNo:G0188195

American Association of Cancer Research, LA Convention Centre, Los Angeles, USA, 14/4/2007 - 18/4/2007$1,700
Funding Body: University of Newcastle

Project Team
Doctor Nikki Verrills
SchemeRole
Travel GrantChief Investigator
Total AmountFunding StartFunding Finish
$1,70020072007
GNo:G0187550

2006 (6 grants)

The role of protein phosphates in regulating the cytoskeletal dynamics of cancer cells$292,062
Funding Body: NHMRC (National Health & Medical Research Council)

Project Team
Doctor Nikki Verrills
SchemeRole
Training (Postdoctoral) Fellowships - Peter Doherty Biomedical Fellowship (Australia)Chief Investigator
Total AmountFunding StartFunding Finish
$292,06220062010
GNo:G0185634

Live cell imaging facility$149,100
Funding Body: Cancer Institute NSW

Project Team
Doctor Rick Thorne, Doctor Nikki Verrills, Professor Alistair Sim, Professor Gordon Burns
SchemeRole
Infrastructure GrantsInvestigator
Total AmountFunding StartFunding Finish
$149,10020062006
GNo:G0186146

Investigating the functional role of altered expression and point mutations in the tumour suppressor gene PP2A$50,000
Funding Body: Hunter Medical Research Institute

Project Team
Doctor Nikki Verrills
SchemeRole
Special Competitive Research Fund for Early Career Researchers in CancerChief Investigator
Total AmountFunding StartFunding Finish
$50,00020062007
GNo:G0186082

Novel protein phosphatase interactions in cancer$10,000
Funding Body: Hunter Medical Research Institute

Project Team
Doctor Nikki Verrills, Professor Alistair Sim
SchemeRole
Project GrantChief Investigator
Total AmountFunding StartFunding Finish
$10,00020062006
GNo:G0186480

High speed computer for a live cell imaging system$3,000
Funding Body: Hunter Medical Research Institute

Project Team
Doctor Rick Thorne, Professor Gordon Burns, Doctor Nikki Verrills, Professor Alistair Sim
SchemeRole
Equipment GrantInvestigator
Total AmountFunding StartFunding Finish
$3,00020062006
GNo:G0187279

BioRad Mini-PROTEAN3 Electrophoresis system$995
Funding Body: Hunter Medical Research Institute

Project Team
Conjoint Professor Leonie Ashman, Associate Professor Phillip Dickson, Emeritus Professor Peter Dunkley, Professor John Rostas, Professor Judith Scott, Professor Alistair Sim, Doctor Nikki Verrills
SchemeRole
Equipment GrantInvestigator
Total AmountFunding StartFunding Finish
$99520062006
GNo:G0187280

2005 (1 grants)

Europhosphatases Conference 2005, 10-14 July 2005$2,430
Funding Body: University of Newcastle

Project Team
Doctor Nikki Verrills
SchemeRole
Travel GrantChief Investigator
Total AmountFunding StartFunding Finish
$2,43020052005
GNo:G0185546

2004 (1 grants)

12th International Conference on Second Messenger and Phosphoproteins, 3-7 August 2004$2,400
Funding Body: University of Newcastle

Project Team
Doctor Nikki Verrills
SchemeRole
Travel GrantChief Investigator
Total AmountFunding StartFunding Finish
$2,40020042004
GNo:G0184543
Edit

Research Supervision

Number of current supervisions4
Total current UoN PhD EFTSL0.45

For supervisions undertaken at an institution other that the University of Newcastle, details are shown in italics, and the institution name is listed below the program name.

Current Supervision

CommencedProposed
Completion
ProgramSupervisor TypeResearch Title
20082012PhD (Medical Biochemistry)Principal SupervisorTargeting PP2A Activation as a Novel Therapeutic Strategy for Receptor Tyrosine Kinase Driven Leukemia
20072010PHD Biochemistry & Cell Biology
University of Newcastle
Co-SupervisorThe role of protein phosphatases in breast cancer
20062009PHD Biochemistry & Cell Biology
University of Newcastle
Co-SupervisorRole of PP2A in cancer
20062009PHD Biochemistry & Cell Biology
University of Newcastle
Co-SupervisorPP2A in mast cell function

Past Supervision

YearProgramSupervisor TypeResearch Title
2012PhD (Medical Biochemistry)Principal SupervisorThe Role of Protein Phosphatase 2A as a Tumour Suppressor in Breast Cancer
2011PhD (Medical Biochemistry)Principal SupervisorRegulation of Mast Cell Degranulation by Protein Phosphatase 2A
2010PhD (Medical Biochemistry)Principal SupervisorRegulation of the Tumour Suppressor PP2A by Oncogenic Tyrosine Kinases
Edit

Dr Nicole (Nikki) Verrills

Work Phone(02) 4921 5619
Fax(02) 4921 6903
Email
PositionResearch Fellow
School of Biomedical Sciences and Pharmacy
Faculty of Health and Medicine
The University of Newcastle, Australia
Focus AreaMedical Biochemistry
Office
LS3-46,
Life Sciences,
Callaghan
University Drive
Callaghan NSW 2308
Australia
URL:www.newcastle.edu.au/profile/nikki-verrills